The U.S. patent office will review patents on Alexion Pharmaceuticals Inc’s blood disorder treatment Soliris, after Amgen Inc challenged them, court filings showed on Friday.
USITC to investigate Resmed for alleged patent infringement
October 6, 2018By
The U.S. International Trade Commission (USITC) said on Friday it would investigate California-based Resmed Inc for a patent infringement complaint related to sleep apnea mask systems.
